GB9708694D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB9708694D0 GB9708694D0 GBGB9708694.6A GB9708694A GB9708694D0 GB 9708694 D0 GB9708694 D0 GB 9708694D0 GB 9708694 A GB9708694 A GB 9708694A GB 9708694 D0 GB9708694 D0 GB 9708694D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9708694.6A GB9708694D0 (en) | 1997-04-30 | 1997-04-30 | Compounds |
CA002288308A CA2288308A1 (en) | 1997-04-30 | 1998-04-27 | Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
PCT/EP1998/002581 WO1998049145A1 (en) | 1997-04-30 | 1998-04-27 | Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
EP98929278A EP0981516A1 (en) | 1997-04-30 | 1998-04-27 | Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d?3 receptors |
JP54662098A JP2001522366A (ja) | 1997-04-30 | 1998-04-27 | ドーパミンd▲上3▼受容体のモジュレーターとしての置換テトラヒドロイソキノリン誘導体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9708694.6A GB9708694D0 (en) | 1997-04-30 | 1997-04-30 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9708694D0 true GB9708694D0 (en) | 1997-06-18 |
Family
ID=10811545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9708694.6A Pending GB9708694D0 (en) | 1997-04-30 | 1997-04-30 | Compounds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0981516A1 (ja) |
JP (1) | JP2001522366A (ja) |
CA (1) | CA2288308A1 (ja) |
GB (1) | GB9708694D0 (ja) |
WO (1) | WO1998049145A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
WO1998050364A1 (en) | 1997-05-03 | 1998-11-12 | Smithkline Beecham Plc | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
US6605607B1 (en) | 1998-10-08 | 2003-08-12 | Smithkline Beecham P.L.C. | Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
AR022228A1 (es) * | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion |
JP2007500730A (ja) * | 2003-07-31 | 2007-01-18 | ワシントン ユニバーシティ イン セント ルイス | 固形癌の増殖状態を画像化するためのシグマ−2受容体ラジオトレーサー |
US20080275028A1 (en) * | 2004-07-20 | 2008-11-06 | Giovanni Gaviraghi | Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof |
CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
WO2016034673A1 (en) | 2014-09-03 | 2016-03-10 | Ctxt Pty Ltd | Tetrahydroisoquinoline derived prmt5-inhibitors |
WO2016034671A1 (en) | 2014-09-03 | 2016-03-10 | Ctxt Pty Ltd | Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived prmt5-inhibitors |
GB201415573D0 (en) | 2014-09-03 | 2014-10-15 | Cancer Therapeutics Crc Pty Ltd | Compounds |
GB201604030D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604031D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604020D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604022D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604027D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
GB201604029D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
WO2018021447A1 (ja) * | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
EP3744721A4 (en) | 2018-01-26 | 2021-11-10 | Shionogi & Co., Ltd | CONDENSED CYCLIC COMPOUND WITH ANTAGONISM TO DOPAMINE D3 RECEPTOR |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2618149B1 (fr) * | 1987-07-16 | 1989-09-22 | Synthelabo | Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique |
US5294621A (en) * | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
ATE232850T1 (de) * | 1996-05-11 | 2003-03-15 | Smithkline Beecham Plc | Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren |
JP2000517301A (ja) * | 1996-08-14 | 2000-12-26 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | テトラヒドロイソキノリン誘導体およびそれらの薬理学的使用 |
-
1997
- 1997-04-30 GB GBGB9708694.6A patent/GB9708694D0/en active Pending
-
1998
- 1998-04-27 WO PCT/EP1998/002581 patent/WO1998049145A1/en not_active Application Discontinuation
- 1998-04-27 JP JP54662098A patent/JP2001522366A/ja active Pending
- 1998-04-27 EP EP98929278A patent/EP0981516A1/en not_active Withdrawn
- 1998-04-27 CA CA002288308A patent/CA2288308A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2288308A1 (en) | 1998-11-05 |
JP2001522366A (ja) | 2001-11-13 |
EP0981516A1 (en) | 2000-03-01 |
WO1998049145A1 (en) | 1998-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9714102D0 (en) | Compounds | |
GB9715584D0 (en) | Compounds | |
GB9708694D0 (en) | Compounds | |
GB9708805D0 (en) | Compounds | |
GB9709303D0 (en) | Compounds | |
EP0999205A4 (en) | AMINOCYCLOALKAN CONNECTIONS | |
GB9711492D0 (en) | Compounds | |
GB9704522D0 (en) | Compounds | |
GB9712849D0 (en) | Compounds | |
GB9702978D0 (en) | Compounds | |
GB9718392D0 (en) | Compounds | |
GB9716212D0 (en) | Compounds | |
GB9704648D0 (en) | Compounds | |
GB9702646D0 (en) | Compounds | |
GB9702608D0 (en) | Compounds | |
GB9704652D0 (en) | Compounds | |
GB9702607D0 (en) | Compounds | |
GB9705188D0 (en) | Compounds | |
GB9704580D0 (en) | Compounds | |
GB9705189D0 (en) | Compounds | |
GB9705194D0 (en) | Compounds | |
GB9705652D0 (en) | Compounds | |
GB9706110D0 (en) | Compounds | |
GB9708976D0 (en) | Compounds | |
GB9704551D0 (en) | Compounds |